Archived documents
Documents past their public comment period for FDA.
FDA ▾
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products
0 comments
Analysis in progress
Top issues in comments
Agency Information Collection Activities; Proposals, Submissions, and Approvals: Required Warnings for Cigarette Packages and Advertisements
0 comments
Analysis in progress
Top issues in comments
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions
0 comments
Analysis in progress
Top issues in comments
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program
0 comments
Analysis in progress
Top issues in comments
Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments; Reopening of the Comment Period
0 comments
Analysis in progress
Top issues in comments
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Adverse Experience/Events With Approved New Animal Drugs
0 comments
Analysis in progress
Top issues in comments
Advancing the Use of Digital Health Technologies in Clinical Investigations for Drugs and Biological Products; Request for Information and Comments
0 comments
Analysis in progress
Top issues in comments
Agency Information Collection Activities; Proposed Collection; Comment Request; Importation of Prescription Drugs
0 comments
Analysis in progress
Top issues in comments
List of Bulk Drug Substances for which there Is a Clinical Need the Federal Food, Drug, and Cosmetic Act
0 comments
Analysis in progress
Top issues in comments
